Results
Displaying results 81 to 100 out of 535
Filters
![](https://www.rhsupplies.org/typo3temp/assets/images/3fb5600c47.png)
Published in 2000
Albania - Multiple Indicator Cluster Survey - 2000
UNICEF (MICS) Multiple Indicator Cluster Survey
![](https://www.rhsupplies.org/typo3temp/assets/images/e4c43463db.png)
Published in 2000
Albania Multiple Indicator Cluster Survey 2000
UNICEF (MICS) Multiple Indicator Cluster Survey
![](https://www.rhsupplies.org/typo3temp/assets/images/ebe8a6bb70.png)
Published in 2013
Regimen Update: Timing and dosage of levonorgestrel-alone emergency contraceptive pills
The International Consortium on Emergency Contraception
![](https://www.rhsupplies.org/typo3temp/assets/images/4c5929fbff.png)
Published in 2013
Algeria - Multiple Indicator Cluster Survey - 2013
UNICEF (MICS) Multiple Indicator Cluster Survey
![](https://www.rhsupplies.org/typo3temp/assets/images/58c798acd9.png)
Published in 2013
ICEC - Over-the-Counter Access to Emergency Contraceptive Pills, 2013
The International Consortium on Emergency Contraception
![](https://www.rhsupplies.org/typo3temp/assets/images/f23a227fc4.png)
Published in 2013
Maternal death surveillance and response: technical guidance information for action to prevent maternal death.
DFID Health Resource Centre
![](https://www.rhsupplies.org/typo3temp/assets/images/cd996d14de.png)
Published in 2022
Ley Cenabast y anticoncepción: información y beneficios para consumidoras
RHSC: General
![](https://www.rhsupplies.org/typo3temp/assets/images/fb997f2a48.png)
Published in 2022
Médicaments pour la prévention et le traitement de l’hémorragie du post-partum et d’autres indications obstétricales
RHSC: General USAID Publication
![](https://www.rhsupplies.org/typo3temp/assets/images/6c6ac1a750.png)
Published in 2004
Processes and Issues for Improving Access to Medicines- The evidence base for domestic production and greater access to medicines
DFID Health Resource Centre
![](https://www.rhsupplies.org/typo3temp/assets/images/746cda1622.png)
Published in 2004
Access to Medicines in Under-served Markets: What are the implications of changes in intellectual property rights, trade and drug registration policy?
DFID Health Resource Centre